RHJA
ACA icon

Rice Hall James & Associates’s Arcosa ACA Stock Holding History

Rice Hall James & Associates’s Portfolio ACA Stock Details ACA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-64,036
Closed -$2.97M – 266
2022
Q2 		$2.97M Sell
64,036
-701
-1% -$36.7K 0.14% 143
2022
Q1 		$3.71M Sell
64,737
-443
-0.7% -$22.8K 0.15% 138
2021
Q4 		$3.44M Buy
65,180
+21,185
+48% +$1.13M 0.12% 161
2021
Q3 		$2.21M Sell
43,995
-412
-0.9% -$21.4K 0.08% 190
2021
Q2 		$2.61M Sell
44,407
-14,656
-25% -$906K 0.09% 171
2021
Q1 		$3.84M Sell
59,063
-1,163
-2% -$71.4K 0.13% 130
2020
Q4 		$3.31M Sell
60,226
-21,492
-26% -$1.1M 0.12% 130
2020
Q3 		$3.6M Sell
81,718
-47,615
-37% -$2.09M 0.15% 117
2020
Q2 		$5.46M Buy
+129,333
New +$4.98M 0.23% 110

Other funds holding ACA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Rice Hall James & Associates's ACA Position: Q3 2022 in Review

Rice Hall James & Associates sold out of Arcosa (ACA) in Q3 2022, closing a stake of 64,036 shares — an estimated $2.97M sold.

Rice Hall James & Associates first reported a position in ACA in Q2 2020 and held it in 9 quarters. The position peaked at $5.46M in Q2 2020. 265 funds tracked by Wall St. Rank hold ACA as of Q3 2022.

  • Rice Hall James & Associates reported no remaining Arcosa position as of Q3 2022 after selling out during the quarter.
  • Rice Hall James & Associates sold 64,036 Arcosa shares in Q3 2022, an estimated $2.97M.
  • Rice Hall James & Associates first reported a position in Arcosa in Q2 2020 and held it in 9 quarters.
  • Rice Hall James & Associates's Arcosa position peaked at $5.46M in Q2 2020.
  • 265 funds tracked by Wall St. Rank held Arcosa as of Q3 2022.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.